Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role.

Tyagi, Richa; Vaidya, Bhupesh; Sharma, Shyam Sunder

Tyagi, Richa; Vaidya, Bhupesh; Sharma, Shyam Sunder.

Afiliação

Tyagi R; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Mohali, Punjab, India.
Vaidya B; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Mohali, Punjab, India.
Sharma SS; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Mohali, Punjab, India. sssharma@niper.ac.in.

Pharmacol Rep ; 74(5): 790-817, 2022 Oct.

Article em En | MEDLINE | ID: mdl-36149598

Assuntos

Doenças Cardiovasculares; Diabetes Mellitus Tipo 2; Resistência à Insulina; Doenças do Sistema Nervoso; Humanos; Insulina; Lipoproteínas/metabolismo

Palavras-chave

Alzheimer's disease; Insulin resistance; Lipoproteins; Major depressive disorder; Multiple sclerosis; Parkinson's disease

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Doenças do Sistema Nervoso Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google